These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 8242636)
21. Trisomy 3 in renal cell carcinoma. Renshaw AA; Fletcher JA Mod Pathol; 1997 May; 10(5):481-4. PubMed ID: 9160314 [TBL] [Abstract][Full Text] [Related]
22. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease. Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029 [TBL] [Abstract][Full Text] [Related]
23. Evolving classification of renal cell neoplasia. Delahunt B; Velickovic M; Grebe SK Expert Rev Anticancer Ther; 2001 Dec; 1(4):576-84. PubMed ID: 12113090 [TBL] [Abstract][Full Text] [Related]
24. Molecular genetic alterations in superficial and locally advanced human bladder cancer. Presti JC; Reuter VE; Galan T; Fair WR; Cordon-Cardo C Cancer Res; 1991 Oct; 51(19):5405-9. PubMed ID: 1680549 [TBL] [Abstract][Full Text] [Related]
25. Allelic loss of 3p25 associated with alterations of 5q22.3 approximately q23.2 may affect the prognosis of conventional renal cell carcinoma. Nagao K; Yamaguchi S; Matsuyama H; Korenaga Y; Hirata H; Yoshihiro S; Fukunaga K; Oba K; Naito K Cancer Genet Cytogenet; 2005 Jul; 160(1):43-8. PubMed ID: 15949569 [TBL] [Abstract][Full Text] [Related]
26. Analysis of 3p allelic loss in papillary and nonpapillary renal cell carcinomas. Correlation with tumor karyotypes. Hughson MD; Meloni A; Dougherty S; Silva FG; Sandberg AA Cancer Genet Cytogenet; 1996 Apr; 87(2):133-9. PubMed ID: 8625259 [TBL] [Abstract][Full Text] [Related]
27. Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma. Schwerdtle RF; Störkel S; Neuhaus C; Brauch H; Weidt E; Brenner W; Hohenfellner R; Huber C; Decker HJ Cancer Res; 1996 Jul; 56(13):2927-30. PubMed ID: 8674042 [TBL] [Abstract][Full Text] [Related]
28. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225 [TBL] [Abstract][Full Text] [Related]
29. Loss of chromosomes in clear cell renal cell carcinoma and in corresponding renal parenchyma. Feil G; Leipoldt M; Nelde HJ; Wunderer A; Wechsel HW; Kaiser P; Bichler KH Anticancer Res; 1999; 19(2C):1477-82. PubMed ID: 10365127 [TBL] [Abstract][Full Text] [Related]
30. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216 [TBL] [Abstract][Full Text] [Related]
31. Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas. Herbers J; Schullerus D; Müller H; Kenck C; Chudek J; Weimer J; Bugert P; Kovacs G Genes Chromosomes Cancer; 1997 May; 19(1):29-35. PubMed ID: 9135992 [TBL] [Abstract][Full Text] [Related]
32. Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. Morita R; Saito S; Ishikawa J; Ogawa O; Yoshida O; Yamakawa K; Nakamura Y Cancer Res; 1991 Nov; 51(21):5817-20. PubMed ID: 1682036 [TBL] [Abstract][Full Text] [Related]
33. [Genetics of renal tumors]. Oláh E; Jakab Z; Balogh E Orv Hetil; 2001 Jul; 142(26):1367-73. PubMed ID: 11478032 [TBL] [Abstract][Full Text] [Related]
34. Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas. Schwerdtle RF; Winterpacht A; Störkel S; Brenner W; Hohenfellner R; Zabel B; Huber C; Decker HJ Cancer Res; 1997 Nov; 57(22):5009-12. PubMed ID: 9371493 [TBL] [Abstract][Full Text] [Related]
35. Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas. Shridhar V; Wang L; Rosati R; Paradee W; Shridhar R; Mullins C; Sakr W; Grignon D; Miller OJ; Sun QC; Petros J; Smith DI Oncogene; 1997 Mar; 14(11):1269-77. PubMed ID: 9178887 [TBL] [Abstract][Full Text] [Related]
36. Dissecting karyotypic patterns in renal cell carcinoma: an analysis of the accumulated cytogenetic data. Höglund M; Gisselsson D; Soller M; Hansen GB; Elfving P; Mitelman F Cancer Genet Cytogenet; 2004 Aug; 153(1):1-9. PubMed ID: 15325087 [TBL] [Abstract][Full Text] [Related]
37. Introduction of normal chromosome 3p modulates the tumorigenicity of a human renal cell carcinoma cell line YCR. Shimizu M; Yokota J; Mori N; Shuin T; Shinoda M; Terada M; Oshimura M Oncogene; 1990 Feb; 5(2):185-94. PubMed ID: 1969617 [TBL] [Abstract][Full Text] [Related]
38. Loss of 14q31-q32.2 in renal cell carcinoma is associated with high malignancy grade and poor survival. Alimov A; Sundelin B; Wang N; Larsson C; Bergerheim U Int J Oncol; 2004 Jul; 25(1):179-85. PubMed ID: 15202004 [TBL] [Abstract][Full Text] [Related]
39. [Analysis of kidney tumors in trichloroethylene exposed workers by comparative genomic hybridization and DNA sequence analysis]. Schraml P; Zhaou M; Richter J; Brüning T; Pommer M; Sauter G; Mihatsch MJ; Moch H Verh Dtsch Ges Pathol; 1999; 83():218-24. PubMed ID: 10714214 [TBL] [Abstract][Full Text] [Related]
40. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Gobbo S; Eble JN; Grignon DJ; Martignoni G; MacLennan GT; Shah RB; Zhang S; Brunelli M; Cheng L Am J Surg Pathol; 2008 Aug; 32(8):1239-45. PubMed ID: 18594469 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]